Integrating Your Drug-Device Development Cycle to Engineer a Safe, Reliable, and Self-Administered Injectable with Speed-to-Market
We are excited for the return of the 12th Annual Injectables Summit and are dedicated to serve this community to design a world-class injectable for complex formulation, functionality, regulatory compliance & usability in mind
Join 120+ Device Design & Development, Engineering, CMC, and Quality experts this September in Boston to share their recent experience and discuss best practice to accelerate smooth regulatory filing for speed-to-market, serving our patients in need.
Be part of the conversation with leading minds of combination product development and experience a 3-day packed agenda built with Merck, Takeda, and Eli Lilly, with practical takeaways including:
- Integrating drug-device product development from the get-go
- Implementing analytical development, design control, EPR, CQA for your injectable combination product
- Designing and engineering the right injectable device for complex formulation and intended patient use
- Exploring the next generation of injectables for high volume on-body and novel primary container
- Assessing regulatory requirements globally
- Performing ‘bridging’ studies and strategic platforming for flexibility